Marking 35 Years of Mission-driven Science
A message from MHRP Director COL Julie Ake
Congress established MHRP in 1986 with the primary mission to develop a safe, effective vaccine. Fast forward to 2009, when we announced the results of the RV144 Thai study, the first HIV vaccine trial to show modest ability to protect people against this disease, demonstrating that such a feat is possible.
2021 marks MHRP’s 35th anniversary. This year we will launch three strategic vaccine studies to test novel vaccine antigens and adjuvants, as well as to optimize dosing of vaccine components. These studies play to the strengths of our program and approach HIV vaccine research and development from new angles.
Although we haven’t yet achieved our ultimate goal of an HIV vaccine, the last year has proven that a spirit of perseverance and collaboration can yield results beyond what previous experience has shown us is possible. MHRP will continue to work towards its mission to protect service members and reduce global impact of HIV until together with partners around the world we can end this continuing pandemic.
Explore the resources in the sidebar to learn more about MHRP and its impact on the field of HIV research through the years.